LTS Lohmann Therapie-Systeme AG

First product based on LTS’ Sorrel(TM) wearable drug delivery platform launched in the US

LTS receives $4.3 Million grant for the development of contraceptive Microneedle Array Patches

LTS receives grant of $1.2 Million to support the development of thermostable mRNA formulations for Microneedle Array Patches

LTS completes its entry into large molecule drug delivery with the acquisition of the Sorrel wearable injection device business

LTS expands into large molecule drug delivery with the acquisition of the Sorrel wearable injection device business

Andernach, Germany (ots) - LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches (“TTS”), Oral Thin Films (“OTF”) and Micro Array Patches (“MAP”) announces the signing of the ...